Cure Model Survival Analysis After Hepatic Resection for Colorectal Liver Metastases

Annals of Surgical Oncology

Volumn 22, Issue 6, 2015, Pages 1908-1914

  Cucchetti, Alessando ^a   Ferrero, Alessandro ^b   Cescon, Matteo ^a   Donadon, Matteo ^c   Russolillo, Nadia ^b   Ercolani, Giorgio ^a   Stacchini, Giacomo ^a   Mazzotti, Federico ^a   Torzilli, Guido ^c   Pinna, Antonio Daniele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b MAURIZIANO HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CANCER STAGING; COLORECTAL NEOPLASMS; FEMALE; FOLLOW UP; HUMAN; LIVER NEOPLASMS; LIVER RESECTION; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; SECONDARY; STATISTICAL MODEL; SURVIVAL RATE; TUMOR INVASION;

AGED; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 84939965167     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-4234-0     Document Type: Article

References (20)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
2. US Cancer Statistics Working Group. United States cancer statistics: 1999–2010 incidence and mortality Web-based report. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2013. Available at: http://www.cdc.gov/uscs. Accessed 1 Feb 2014.
3. Garden OJ, Rees M, Poston GJ, et al. Guidelines for resection of colorectal cancer liver metastases. Gut. 2006;55(Suppl 3):iii1–8.
4. Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;25:4575–80.
5. Pulitanò C, Castillo F, Aldrighetti L, et al. What defines “cure” after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB (Oxford). 2010;12:244–9.
6. Statistical Methodology and Applications Branch, Data Modeling Branch, National Cancer Institute. Cansurv, version 1.1. Available at: http://surveillance.cancer.gov/cansurv/index.html. Accessed 1 Feb 2014.
7. Othus M, Barlogie B, Leblanc ML, et al. Cure models as a useful statistical tool for analyzing survival. Clin Cancer Res. 2012;18:3731–6.
8. Lambert PC, Thompson JR, Weston CL, et al. Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics. 2007;8:576–94.
9. Terminology Committee of the IHPBA. The Brisbane 2000 terminology of liver anatomy and resections. Abingdon: Taylor & Francis; 2000. p. 333–9.
10. Smoll NR, Schaller K, Gautschi OP. The cure fraction of glioblastoma multiforme. Neuroepidemiology. 2012;39:63–9.
11. Fuller AF, Griffiths CT. Gynecologic oncology. Amsterdam: Wolters Kluwer; 1983.
12. Lambert PC. Modeling of the cure fraction in survival studies. Stata J. 2007;3:1–25.
13. Tsodikov AD, Ibrahim JG, Yakovlev AY. Estimating cure rates from survival data: an alternative to two-component mixture models. J Am Stat Assoc. 2003;98:1063–78.
14. Italian population life tables. Available at: http://demo.istat.it/. Accessed 1 Dec 2013.
15. Adam R, Bismuth H, Castaing D, et al. Repeat hepatectomy for colorectal liver metastases. Ann Surg. 1997;225:51–60.
16. Adam R, De Gramont A, Figueras J, et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012;17:1225–39.
17. Cvancarova M, Aagnes B, Fosså SD, et al. Proportion cured models applied to 23 cancer sites in Norway. Int J Cancer. 2013;132:1700–10.
18. Dal Maso L, Guzzinati S, Buzzoni C, et al. Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818,902 Italian patients and 26 cancer types. Ann Oncol. 2014;25:2251-60.
19. Viganò L, Capussotti L, Lapointe R, et al. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol. 2014;21(4):1276–1286.
20. Tai P, Yu E, Cserni G, et al. Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database. BMC Cancer. 2005;5:48.